These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31526687)

  • 1. Potential Role of Convolutional Neural Network Based Algorithm in Patient Selection for DCIS Observation Trials Using a Mammogram Dataset.
    Mutasa S; Chang P; Van Sant EP; Nemer J; Liu M; Karcich J; Patel G; Jambawalikar S; Ha R
    Acad Radiol; 2020 Jun; 27(6):774-779. PubMed ID: 31526687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast.
    Mutasa S; Chang P; Nemer J; Van Sant EP; Sun M; McIlvride A; Siddique M; Ha R
    Clin Breast Cancer; 2020 Dec; 20(6):e757-e760. PubMed ID: 32680766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Distinguishing Atypical Ductal Hyperplasia From Ductal Carcinoma In Situ With Convolutional Neural Network-Based Machine Learning Approach Using Mammographic Image Data.
    Ha R; Mutasa S; Sant EPV; Karcich J; Chin C; Liu MZ; Jambawalikar S
    AJR Am J Roentgenol; 2019 May; 212(5):1166-1171. PubMed ID: 30860901
    [No Abstract]   [Full Text] [Related]  

  • 4. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary Lymph Node Evaluation Utilizing Convolutional Neural Networks Using MRI Dataset.
    Ha R; Chang P; Karcich J; Mutasa S; Fardanesh R; Wynn RT; Liu MZ; Jambawalikar S
    J Digit Imaging; 2018 Dec; 31(6):851-856. PubMed ID: 29696472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convolutional Neural Network Based Breast Cancer Risk Stratification Using a Mammographic Dataset.
    Ha R; Chang P; Karcich J; Mutasa S; Pascual Van Sant E; Liu MZ; Jambawalikar S
    Acad Radiol; 2019 Apr; 26(4):544-549. PubMed ID: 30072292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    J Am Coll Radiol; 2018 Mar; 15(3 Pt B):527-534. PubMed ID: 29398498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Breast Cancer Molecular Subtype with MRI Dataset Utilizing Convolutional Neural Network Algorithm.
    Ha R; Mutasa S; Karcich J; Gupta N; Pascual Van Sant E; Nemer J; Sun M; Chang P; Liu MZ; Jambawalikar S
    J Digit Imaging; 2019 Apr; 32(2):276-282. PubMed ID: 30706213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presurgical Upgrade Prediction of DCIS to Invasive Ductal Carcinoma Using Time-dependent Deep Learning Models with DCE MRI.
    Mayfield JD; Ataya D; Abdalah M; Stringfield O; Bui MM; Raghunand N; Niell B; El Naqa I
    Radiol Artif Intell; 2024 Sep; 6(5):e230348. PubMed ID: 38900042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel CNN algorithm for pathological complete response prediction using an I-SPY TRIAL breast MRI database.
    Liu MZ; Mutasa S; Chang P; Siddique M; Jambawalikar S; Ha R
    Magn Reson Imaging; 2020 Nov; 73():148-151. PubMed ID: 32889091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
    Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
    Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fully Automated Convolutional Neural Network Method for Quantification of Breast MRI Fibroglandular Tissue and Background Parenchymal Enhancement.
    Ha R; Chang P; Mema E; Mutasa S; Karcich J; Wynn RT; Liu MZ; Jambawalikar S
    J Digit Imaging; 2019 Feb; 32(1):141-147. PubMed ID: 30076489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI.
    Amitai Y; Menes TS; Scaranelo A; Fleming R; Kulkarni S; Ghai S; Wey L; Mulligan AM; Mrkonjic M; Freitas VAR
    Breast Cancer Res Treat; 2021 Nov; 190(2):317-327. PubMed ID: 34476644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Underestimation of Invasive Cancer in Patients with Core-Needle-Biopsy-Diagnosed Ductal Carcinoma In Situ Using Deep Learning Algorithms.
    Do LN; Lee HJ; Im C; Park JH; Lim HS; Park I
    Tomography; 2022 Dec; 9(1):1-11. PubMed ID: 36648988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence Score.
    Ha R; Chang P; Mutasa S; Karcich J; Goodman S; Blum E; Kalinsky K; Liu MZ; Jambawalikar S
    J Magn Reson Imaging; 2019 Feb; 49(2):518-524. PubMed ID: 30129697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.
    Grimm LJ; Miller MM; Thomas SM; Liu Y; Lo JY; Hwang ES; Hyslop T; Ryser MD
    Radiology; 2019 Jul; 292(1):77-83. PubMed ID: 31112087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype.
    Slanetz PJ; Giardino AA; Oyama T; Koerner FC; Halpern EF; Moore RH; Kopans DB
    Breast J; 2001; 7(6):417-21. PubMed ID: 11843854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Lehman CD; Oseni TO; Bahl M
    Acad Radiol; 2020 Oct; 27(10):1394-1399. PubMed ID: 31699638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.